136 related articles for article (PubMed ID: 29542379)
1. Investigating the selectivity of potential new inhibitors of dihydrofolate reductase from Yersinia pestis designed by molecular modeling.
Bastos LDC; de Souza FR; Pereira Souza LM; Forgione P; Cuya T; de Alencastro RB; Pimentel AS; Celmar Costa França T
J Biomol Struct Dyn; 2019 Mar; 37(5):1170-1176. PubMed ID: 29542379
[No Abstract] [Full Text] [Related]
2. Virtual screening, docking, and dynamics of potential new inhibitors of dihydrofolate reductase from Yersinia pestis.
Bastos Lda C; de Souza FR; Guimarães AP; Sirouspour M; Cuya Guizado TR; Forgione P; Ramalho TC; França TC
J Biomol Struct Dyn; 2016 Oct; 34(10):2184-98. PubMed ID: 26494420
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling studies of Yersinia pestis dihydrofolate reductase.
Oliveira AA; Rennó MN; de Matos CA; Bertuzzi MD; Ramalho TC; Fraga CA; França TC
J Biomol Struct Dyn; 2011 Oct; 29(2):351-67. PubMed ID: 21875154
[TBL] [Abstract][Full Text] [Related]
4. Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium.
Bolstad DB; Bolstad ES; Frey KM; Wright DL; Anderson AC
J Med Chem; 2008 Nov; 51(21):6839-52. PubMed ID: 18834108
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling toward selective inhibitors of dihydrofolate reductase from the biological warfare agent Bacillus anthracis.
Giacoppo JO; Mancini DT; Guimarães AP; Gonçalves AS; da Cunha EF; França TC; Ramalho TC
Eur J Med Chem; 2015 Feb; 91():63-71. PubMed ID: 24985033
[TBL] [Abstract][Full Text] [Related]
6. A DFT-based QSAR study on inhibition of human dihydrofolate reductase.
Karabulut S; Sizochenko N; Orhan A; Leszczynski J
J Mol Graph Model; 2016 Nov; 70():23-29. PubMed ID: 27649548
[TBL] [Abstract][Full Text] [Related]
7. The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling.
Hong W; Wang Y; Chang Z; Yang Y; Pu J; Sun T; Kaur S; Sacchettini JC; Jung H; Lin Wong W; Fah Yap L; Fong Ngeow Y; Paterson IC; Wang H
Sci Rep; 2015 Oct; 5():15328. PubMed ID: 26471125
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Coxiela burnetti dihydrofolate reductase via in silico docking with inhibitors and molecular dynamics simulation.
de Souza FR; Guimarães AP; Cuya T; de Freitas MP; Gonçalves ADS; Forgione P; Costa França TC
J Biomol Struct Dyn; 2017 Oct; 35(13):2975-2986. PubMed ID: 27726597
[TBL] [Abstract][Full Text] [Related]
9. Targeting species specific amino acid residues: Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors and potential anti-opportunistic infection agents.
Shah K; Lin X; Queener SF; Cody V; Pace J; Gangjee A
Bioorg Med Chem; 2018 May; 26(9):2640-2650. PubMed ID: 29691153
[TBL] [Abstract][Full Text] [Related]
10. The structure and competitive substrate inhibition of dihydrofolate reductase from Enterococcus faecalis reveal restrictions to cofactor docking.
Bourne CR; Wakeham N; Webb N; Nammalwar B; Bunce RA; Berlin KD; Barrow WW
Biochemistry; 2014 Feb; 53(7):1228-38. PubMed ID: 24495113
[TBL] [Abstract][Full Text] [Related]
11. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.
da Cunha EF; de Castro Ramalho T; Bicca de Alencastro R; Maia ER
J Biomol Struct Dyn; 2004 Oct; 22(2):119-30. PubMed ID: 15317473
[TBL] [Abstract][Full Text] [Related]
12. Identification of Selective Inhibitors of
Sharma VK; Bharatam PV
J Comput Biol; 2021 Jan; 28(1):43-59. PubMed ID: 32207987
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase.
Liu J; Bolstad DB; Smith AE; Priestley ND; Wright DL; Anderson AC
Chem Biol; 2008 Sep; 15(9):990-6. PubMed ID: 18804036
[TBL] [Abstract][Full Text] [Related]
14. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
15. Rational modification of the lead molecule: Enhancement in the anticancer and dihydrofolate reductase inhibitory activity.
Kaur J; Kaur S; Singh P
Bioorg Med Chem Lett; 2016 Apr; 26(8):1936-40. PubMed ID: 26979156
[TBL] [Abstract][Full Text] [Related]
16. A new procedure for improving the predictiveness of CoMFA models and its application to a set of dihydrofolate reductase inhibitors.
Kroemer RT; Hecht P
J Comput Aided Mol Des; 1995 Oct; 9(5):396-406. PubMed ID: 8594157
[TBL] [Abstract][Full Text] [Related]
17. Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.
Jayaraman P; Sakharkar KR; Lim C; Siddiqi MI; Dhillon SK; Sakharkar MK
Drug Des Devel Ther; 2013; 7():449-75. PubMed ID: 23818757
[TBL] [Abstract][Full Text] [Related]
18. Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.
Rastelli G; Sirawaraporn W; Sompornpisut P; Vilaivan T; Kamchonwongpaisan S; Quarrell R; Lowe G; Thebtaranonth Y; Yuthavong Y
Bioorg Med Chem; 2000 May; 8(5):1117-28. PubMed ID: 10882022
[TBL] [Abstract][Full Text] [Related]
19. Structural Insights of Three 2,4-Disubstituted Dihydropyrimidine-5-carbonitriles as Potential Dihydrofolate Reductase Inhibitors.
Al-Wahaibi LH; Shaik A; Elmorsy MA; Abdelbaky MSM; Garcia-Granda S; Thamotharan S; Thiruvenkatam V; El-Emam AA
Molecules; 2021 May; 26(11):. PubMed ID: 34072467
[TBL] [Abstract][Full Text] [Related]
20. Homology modeling of dihydrofolate reductase from T. gondii bonded to antagonists: molecular docking and molecular dynamics simulations.
Pacheco Homem D; Flores R; Tosqui P; de Castro Rozada T; Abicht Basso E; Gasparotto A; Augusto Vicente Seixas F
Mol Biosyst; 2013 Jun; 9(6):1308-15. PubMed ID: 23450239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
